Round-up of European consumer health business news: Germany's PharmaSGP breaks sales record in Q1 as acquired brands grow; probiotics player BioGaia plans direct distribution in Canada; and private-equity firm Ardian takes a stake in French e-commerce supplements specialist Nutripure.

Women’s health company acquired patent for SAM-e formulation MSI-195 after innovator's study showed it had nearly three times higher availability than a leading competitor.

A round-up of European consumer health business news: Dermapharm sees 2021 sales rise on the back of increased vitamin D demand; Sanofi plans to launch Enzymatica's ColdZyme in Turkey; and Slovenia's Krka posts rise in OTC sales.

A round-up of the latest European consumer health industry appointments: Alliance Pharma names Jo LeCouilliard as chair; Venture Life hires Paul McGreevy as non-executive chair; and Maxwellia appoints Ian Adamson as a strategic advisor.

Democrats and Republicans vote to approve $28m emergency finding for FDA formula programs proposed in bill introduced day earlier by Democrat leaders on Appropriations Committee. Biden deems Defense Production Act applicable to manufacturing formula products.

HELP Committee Chairwoman Patty Murray, and ranking member Richard Burr also include supplement registration requirement in discussion draft for reauthorizing FDA’s user fee programs for prescription, generic and biosimilar drugs and medical devices.

Round-up of European consumer health business news: Germany's PharmaSGP breaks sales record in Q1 as acquired brands grow; probiotics player BioGaia plans direct distribution in Canada; and private-equity firm Ardian takes a stake in French e-commerce supplements specialist Nutripure.

Due to uncertainty in COVID-19 landscape in China, USANA adjusted its 2022 fiscal year guidance. Direct seller Mannatech decreased its number of fulfilled orders by 6% in the first quarter.

Tru Niagen sales made up more than 85% of first-quarter total, and TV ads launched in March drove a “dramatic increase” in customers, says CEO Robert Fried.

Decree imposes steps Abbott must complete before it can begin preparing to restart production, including hiring independent consultant to determine whether facility is compliant with FDA manufacturing and labeling regulations.

FDA launches temporary enforcement discretion on infant formula product to help increase supply in US on same day consent decree announced to allow Abbott to restart production at facility closed since February, prompting ongoing formula shortage. 

Doesn’t take long to find health and wellness product marketers on list of direct sellers or find firms offering those products in the FTC's history of enforcement actions in the sector.